Project Grant R34CA286879
Award Date
9/17/24
Completion Date
8/31/27
Dollars Obligated
$578K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $402,401 to the University of Missouri System to conduct a pilot study on the feasibility and impact of a metacognitive strategy training (MCST) intervention for women with cancer-related cognitive impairment (CRCI) following breast cancer treatment. The study aims to examine the effects of MCST on cognitive performance, frontoparietal neural functioning, and functional...
The National Cancer Institute (NCI) awarded a $403,383 Project Grant (CFDA 93.395 - Cancer Treatment Research) to the Medstar Health Research Institute Inc. to develop and pilot test a new virtual reality (VR) therapy that integrates cognitive behavioral therapy (CBT) strategies for managing chronic cancer pain. The goal is to create an evidence-based, patient-centered VR prototype ("VR-CAN") through focus groups, provider interviews, and usability testing, and then conduct a...
This Project Grant award of $586,106 from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower program) supports a 5-year effort to refine and pilot test a psychosocial intervention for patients with malignant primary central nervous system tumors. The intervention incorporates elements of Acceptance and Commitment Therapy to address unmet supportive care needs and alleviate distress in this patient population. Specifically, the project aims to: 1) refine the intervention...
This $656,014 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will fund a randomized clinical trial at The Ohio State University to evaluate the effectiveness of a telemedicine-mHealth symptom management intervention, called FOCUS, for advanced cancer patients in underserved rural communities. The FOCUS intervention aims to improve a symptom cluster including sleep difficulties, anxiety, depression, and fatigue, and enhance functional...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $656,046 to the University of Colorado to conduct a randomized trial of a novel behavioral intervention called EASE. The goal is to address fear of progression and cancer-related trauma symptoms among adults with advanced cancer. The 5-year study, which began on August 1, 2025, will evaluate the EASE intervention delivered via telehealth compared to usual care,...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $671,757 to Virginia Commonwealth University to conduct a randomized controlled trial of a home-based physical activity intervention plus a healthy living intervention, versus the healthy living intervention alone. The goal is to preserve exercise capacity, left ventricular function, and health-related quality of life, and reduce fatigue in 150 women receiving...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $979,000 to the Beckman Research Institute of the City of Hope to develop and test a blended e-health intervention for fear of progression (FOP) in patients with advanced gynecologic cancer. The 2-year project will adapt an existing FOP intervention for delivery via videoconferencing, self-study web modules, and nurse/social worker facilitation. This novel approach aims to increase access and...
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the federal Research and Training in Complementary and Integrative Health grant program (CFDA 93.213), will fund the development and pilot testing of a novel, daily, digitally delivered mindfulness-based intervention for depressive symptoms in post-treatment cancer patients. The $165,240 award, granted to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University,...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support a $1,338,648 hybrid effectiveness-implementation trial of the CARES intervention at the University of Pittsburgh. CARES is an integrated electronic health record-based screening and stepped collaborative care program designed to improve patient-centered outcomes for over 18 million Americans living with cancer who experience clinically significant levels of depression,...
The National Cancer Institute (NCI), under the Federal Grant Program for Cancer Research Manpower (CFDA 93.398), awarded a $135,990 Project Grant to the University of Illinois in Chicago to conduct research on cognition, vascular function, and physical activity in colorectal cancer survivors. The 1.5-year study, beginning January 17, 2025, aims to: (1) compare cognitive processing speed, arterial stiffness, and moderate-to-vigorous physical activity levels between colorectal cancer survivors and...